Comparison of ultralongacting insulin, glargine and degludec in type2 diabetes

INTERVENTION: degludec 4units/day and Quick insulin 4units every meals,then doses of insulin is adjusted according to the algorythm. Glargine 4units/day CONDITION: Type 2 diabetes mellitus PRIMARY OUTCOME: Achievement rate of FPG <110mg/dl and PPG <180mg/dl after treatment with glargine or degludec SECONDARY OUTCOME: 1)Glucose variability, CV.; 2)Achievment rate of <110mg/dl of FPG or 180mg/dl of PPG; 3)FPG and PPG after 2 weeks of treatment; 4)days to achieve target; 5)frequencies of hypoglycemia; 6)Achievment rate of <130mg/dl of FPG or 200mg/dl of PPG; 7)lipid control; 8)MAGE and CV in CGM INCLUSION CRITERIA: 1)before test registration ‐ no insulin therapy and inpatient 2)FPG :more than 200mg/dl, PPG:more than 300mg/dl 3)HbA1c :more than 8.0%, less than 14% 4)Type 2 diabetes 5)Age more than 20, less than 85Type 6)Pts with written IC